Compare Analgesia Between MTP Block And ESPB in MRM

Launched by NATIONAL CANCER INSTITUTE, EGYPT · Mar 20, 2025

Keywords

ClinConnect Summary

This clinical trial is comparing two different methods of pain relief for patients undergoing modified radical mastectomy surgery, which is a type of surgery for breast cancer. The trial will look at the effectiveness of two techniques: one involves injecting medication near the spine (called the Erector Spinae Plane block), and the other involves a different injection method near the ribs (called the midpoint transverse process to pleura block). The goal is to see which method provides better pain control after surgery.

To be eligible for this trial, participants should be between the ages of 18 and 75, have a body mass index (BMI) between 18.5 and 30, and be classified as ASA I or II, which means they are generally healthy or have mild health issues. People who have certain medical conditions, are on blood thinners, or have allergies to local anesthetics cannot participate. Those who join the study can expect to receive one of the two pain relief methods during their surgery and will be monitored to see how well it works. This research is important because finding the best way to manage pain can help improve recovery for breast cancer patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ASA I-II.
• • Undergoing modified radical mastectomy surgery.
• • Body mass index (BMI) from 18.5 to 30 kg/m2
• Exclusion Criteria:
• • Patient refusal.
• • Known allergy to local anesthetics.
• • Bleeding disorders; platelets count \<50,000 , prothrombin concentration \< 60% or any coagulopathy disorder.
• • Use of any anti-coagulants.
• • Inability to provide informed consent.
• • ASA III-IV.
• • Neurological disorders.
• • Patient with psychiatric disorders